Vanguard Capital Management’s Lisata Therapeutics LSTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$402K Hold
278,837
– – ﹤0.01% 3708
2026
Q2
$948K Buy
278,837
+7,022
+3% +$25K ﹤0.01% 3603
2026
Q1
$1.36M Buy
+271,815
New +$1.12M ﹤0.01% 3481

Other funds holding LSTA

Vanguard Capital Management's LSTA Position: Q3 2026 in Review

Vanguard Capital Management held its Lisata Therapeutics (LSTA) position steady in Q3 2026 at 278,837 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #3708.

Vanguard Capital Management first reported a position in LSTA in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.36M in Q1 2026. 39 funds tracked by Wall St. Rank hold LSTA as of Q3 2026.

  • Vanguard Capital Management held 278,837 shares of Lisata Therapeutics worth $402K as of Q3 2026.
  • Vanguard Capital Management left its Lisata Therapeutics share count unchanged in Q3 2026.
  • Lisata Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3708 holding.
  • Vanguard Capital Management first reported a position in Lisata Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Lisata Therapeutics position peaked at $1.36M in Q1 2026.
  • 39 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.